NP
CELG

NorthRock Partners’s Celgene Corp CELG Stock Holding History

NorthRock Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,135
Closed -$311K – 297
2019
Q3 		$311K Sell
3,135
-5,300
-63% -$504K 0.04% 163
2019
Q2 		$780K Sell
8,435
-184
-2% -$17.5K 0.22% 24
2019
Q1 		$814K Sell
8,619
-373
-4% -$32.6K 0.21% 27
2018
Q4 		$579K Buy
8,992
+557
+7% +$41.1K 0.17% 40
2018
Q3 		$755K Buy
8,435
+144
+2% +$12.7K 0.22% 23
2018
Q2 		$660K Sell
8,291
-626
-7% -$52K 0.23% 21
2018
Q1 		$798K Buy
8,917
+507
+6% +$48.7K 0.26% 18
2017
Q4 		$878K Sell
8,410
-200
-2% -$22.6K 0.28% 17
2017
Q3 		$1.25M Hold
8,610
– – 0.48% 14
2017
Q2 		$1.12M Buy
8,610
+525
+6% +$64.3K 0.47% 13
2017
Q1 		$1.01M Sell
8,085
-5,328
-40% -$638K 0.43% 17
2016
Q4 		$1.55M Sell
13,413
-46
-0.3% -$5.12K 0.55% 19
2016
Q3 		$1.41M Buy
13,459
+7,270
+117% +$787K 0.6% 12
2016
Q2 		$571K Buy
6,189
+4,177
+208% +$432K 0.26% 23
2016
Q1 		$202K Sell
2,012
-6,381
-76% -$657K 0.1% 44
2015
Q4 		$994K Sell
8,393
-1,400
-14% -$162K 0.58% 14
2015
Q3 		$1.07M Sell
9,793
-4,001
-29% -$497K 0.68% 14
2015
Q2 		$1.59M Buy
13,794
+156
+1% +$17.8K 0.74% 14
2015
Q1 		$1.57M Buy
13,638
+351
+3% +$41.9K 0.93% 10
2014
Q4 		$1.49M Buy
+13,287
New +$1.4M 0.91% 10

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

NorthRock Partners's CELG Position: Q4 2019 in Review

NorthRock Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,135 shares — an estimated $311K sold.

NorthRock Partners first reported a position in CELG in Q4 2014 and held it in 20 quarters. The position peaked at $1.59M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • NorthRock Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • NorthRock Partners sold 3,135 Celgene Corp shares in Q4 2019, an estimated $311K.
  • NorthRock Partners first reported a position in Celgene Corp in Q4 2014 and held it in 20 quarters.
  • NorthRock Partners's Celgene Corp position peaked at $1.59M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on NorthRock Partners's 13F filing for Q4 2019, filed 12 Feb 2020.